Patents by Inventor András MÁLNÁSI CSIZMADIA

András MÁLNÁSI CSIZMADIA has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Pharmaceutically effective compounds inhibiting selectively the myosin 2 isoforms
    Patent number: 11845758
    Abstract: The present invention relates to compounds of formula (I) or (II) pharmaceutically acceptable salts, solvates, tautomers, stereoisomers thereof, including enantiomers, diastereomers, racemic mixtures, mixtures of enantiomers, or combinations thereof, and pharmaceutical uses of the compounds.
    Type: Grant
    Filed: June 30, 2023
    Date of Patent: December 19, 2023
    Assignees: PRINTNET KERESKEDELMI ÉS SZOLGÁLTATÓ KFT., EÖTVÖS LORÁND TUDOMÁNYEGYETEM
    Inventors: András Málnási-Csizmadia, Máté Gyimesi, András Szabó, Péter Hári, Suthar Sharad Kumar, Mihály Kovács, Ádám István Horváth, Máté Pénzes, István Lörincz, László Végner, Zoltán Simon, Sándor Bátori, Zoltán Szönyegi, Vajik Horváth, József Répási
  • PHARMACEUTICALLY EFFECTIVE COMPOUNDS INHIBITING SELECTIVELY THE MYOSIN 2 ISOFORMS
    Publication number: 20230339959
    Abstract: The present invention relates to compounds of formula (I) or (II) pharmaceutically acceptable salts, solvates, tautomers, stereoisomers thereof, including enantiomers, diastereomers, racemic mixtures, mixtures of enantiomers, or combinations thereof, and pharmaceutical uses of the compounds.
    Type: Application
    Filed: June 30, 2023
    Publication date: October 26, 2023
    Inventors: András MÁLNÁSI-CSIZMADIA, Máté GYIMESI, András SZABÓ, Péter HÁRI, Suthar Sharad KUMAR, Mihály KOVÁCS, Ádám István HORVÁTH, Máté PÉNZES, István LORINCZ, László VÉGNER, Zoltán SIMON, Sándor BÁTORI, Zoltán SZONYEGI, Vajik HORVÁTH, József RÉPÁSI
  • Pharmaceutically effective compounds inhibiting selectively the myosin 2 isoforms
    Patent number: 11746112
    Abstract: The present invention relates to compounds of formula (I) or (II) pharmaceutically acceptable salts, solvates, tautomers, stereoisomers thereof, including enantiomers, diastereomers, racemic mixtures, mixtures of enantiomers, or combinations thereof, and pharmaceutical uses of the compounds.
    Type: Grant
    Filed: April 18, 2019
    Date of Patent: September 5, 2023
    Assignees: EÖTVÖS LORÁND TUDOMÁNYEGYETEM, PRINTNET KERESKEDELMI ÉS SZOLGÁLTATÓ KFT.
    Inventors: András Málnási-Csizmadia, Maté Gyimesi, András Szabó, Péter Hári, Suthar Sharad Kumar, Mihály Kovács, Ádám István Horváth, Máté Pénzes, István Lörincz, László Végner, Zoltán Simon, Sándor Bátori, Zoltán Szönyegi, Vajk Horváth, József Répási
  • PHARMACEUTICALLY EFFECTIVE COMPOUNDS INHIBITING SELECTIVELY THE MYOSIN 2 ISOFORMS
    Publication number: 20210087201
    Abstract: The present invention relates to compounds of formula (I) or (II) pharmaceutically acceptable salts, solvates, tautomers, stereoisomers thereof, including enantiomers, diastereomers, racemic mixtures, mixtures of enantiomers, or combinations thereof, and pharmaceutical uses of the compounds.
    Type: Application
    Filed: April 18, 2019
    Publication date: March 25, 2021
    Inventors: András MÁLNÁSI-CSIZMADIA, Máté GYIMESI, András SZABÓ, Péter HÁRI, Suthar Sharad KUMAR, Mihály KOVÁCS, Ádám István HORVÁTH, Máté PÉNZES, István LORINCZ, László VÉGNER, Zoltán SIMON, Sándor BÁTORI, Zoltán SZONYEGI, Vajk HORVÁTH, József RÉPÁSI
  • Water-soluble myosin 2 inhibitors for the treatment of neurological, neuropathic or psychiatric diseases
    Patent number: 10858357
    Abstract: The present invention relates to highly soluble, non-fluorescent and photostable myosin inhibitors; especially, for in vivo inhibition of the ATPase activity of neuronal non-muscle myosin 2 of formula (II): wherein Q1, Q2, Q3, Q4, R1, R2, R4 and R5 are as defined in claim 1. The invention also relates to pharmaceutical compositions or medicaments comprising the compounds of the invention and processes for manufacturing these compounds and their intermediates.
    Type: Grant
    Filed: January 27, 2017
    Date of Patent: December 8, 2020
    Assignees: PARIS SCIENCES ET LETTRES-QUARTIER LATIN, CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE, INSERM (INSTITUT NATIONAL DE LA SANTÉ ET DE LA RECHERCHE MÉDICALE), PRINTNET LTD.
    Inventors: Zsolt Lenkei, András Málnási Csizmadia, Miklós Képiró, Boglárka Várkuti
  • WATER-SOLUBLE MYOSIN 2 INHIBITORS FOR THE TREATMENT OF NEUROLOGICAL, NEUROPATHIC OR PSYCHIATRIC DISEASES
    Publication number: 20190084979
    Abstract: The present invention relates to highly soluble, non-fluorescent and photostable myosin inhibitors; especially, for in vivo inhibition of the ATPase activity of neuronal non-muscle myosin 2 of formula (II): wherein Q1, Q2, Q3, Q4, R1, R2, R4 and R5 are as defined in claim 1. The invention also relates to pharmaceutical compositions or medicaments comprising the compounds of the invention and processes for manufacturing these compounds and their intermediates.
    Type: Application
    Filed: January 27, 2017
    Publication date: March 21, 2019
    Inventors: Zsolt LENKEI, András MÁLNÁSI CSIZMADIA, Miklós KÉPIRÓ, Boglárka VÁRKUTI